Gail Cawkwell

2021

In 2021, Gail Cawkwell earned a total compensation of $2.6M as SVP Medical Affairs, Safety & Pharmacovigilance at Intercept Pharmaceuticals.

Compensation breakdown

Bonus$750,000
Non-Equity Incentive Plan$216,385
Option Awards$337,855
Salary$478,412
Stock Awards$748,431
Other$31,244
Total$2,562,328

Cawkwell received $750K in bonus, accounting for 29% of the total pay in 2021.

Cawkwell also received $216.4K in non-equity incentive plan, $337.9K in option awards, $478.4K in salary, $748.4K in stock awards and $31.2K in other compensation.

Rankings

In 2021, Gail Cawkwell's compensation ranked 5,059th out of 12,406 executives tracked by ExecPay. In other words, Cawkwell earned more than 59.2% of executives.

ClassificationRankingPercentile
All
5,059
out of 12,406
59th
Division
Manufacturing
2,128
out of 5,494
61st
Major group
Chemicals And Allied Products
911
out of 2,369
62nd
Industry group
Drugs
815
out of 2,090
61st
Industry
Pharmaceutical Preparations
583
out of 1,537
62nd

Pay ratio

Gail Cawkwell's Pay$2,562,328
Median Employee's Pay$216,748
Pay Ratio

12

to 1

In 2021, the annual total compensation of Gail Cawkwell was $2,562,328.

The annual total compensation of the median employee at Intercept Pharmaceuticals was $216,748.

The ratio of Gail Cawkwell's pay to the pay of median employee was therefore 12 to one.

Source: SEC filing on May 2, 2022.

Cawkwell's colleagues

We found six more compensation records of executives who worked with Gail Cawkwell at Intercept Pharmaceuticals in 2021.

2021

Jerome Durso

Intercept Pharmaceuticals

Chief Executive Officer

2021

Jared Freedberg

Intercept Pharmaceuticals

General Counsel

2021

Michelle Berrey

Intercept Pharmaceuticals

Chief Medical Officer

2021

Andrew Saik

Intercept Pharmaceuticals

Chief Financial Officer

2021

Sandip Kapadia

Intercept Pharmaceuticals

Chief Financial Officer

2021

Rocco Venezia

Intercept Pharmaceuticals

Chief Financial Officer

News

You may also like